# Terazosin

NDC: 50268-765
Generic name: Terazosin Hydrochloride
Labeler / Manufacturer: AvPAK
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20200213

FDA application: ANDA075317

## Active ingredients

- TERAZOSIN HYDROCHLORIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50268-765"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50268-765
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e7b27a6-cc09-407e-e053-2a95a90a17b3